- Author:
Seung Young ROH
;
Sung Hwan KIM
;
Yoon Nyun KIM
;
Ju Youn KIM
;
Jun KIM
;
Tae Hoon KIM
;
Gi Byoung NAM
;
Kyoung Min PARK
;
Hyoung Seob PARK
;
Hui Nam PAK
;
Eun Jung BAE
;
Seil OH
;
Namsik YOON
;
Man Young LEE
;
Youngjin CHO
;
Yongkeun CHO
;
Eun Sun JIN
;
Tae Joon CHA
;
Jong Il CHOI
;
Yoo Ri KIM
- Publication Type:Review
- MeSH: Arrhythmias, Cardiac; Catheter Ablation; Catheters; Death, Sudden, Cardiac; Defibrillators; Heart Diseases; Humans; Mortality; Risk Assessment; Shock
- From:International Journal of Arrhythmia 2018;19(2):36-62
- CountryRepublic of Korea
- Language:Korean
- Abstract: Ventricular arrhythmias (VA) are a major cause of sudden cardiac death (SCD) in patients with known heart disease. Risk assessment and effective prevention of SCD are key issues in these patients. Implantable cardioverter defibrillator (ICD) insertion effectively treats sustained VA and reduces mortality in patients at high risk of SCD. Appropriate anti-arrhythmic drugs and catheter ablation reduce the VA burden and the occurrence of ICD shocks. In this guideline, authors have described the general examination and medical treatment of patients with VA. Medications and catheter ablation are also used as acute phase therapy for sustained VA.